17-alpha-hydroxyprogesterone and Bone Loss, Osteoclastic

17-alpha-hydroxyprogesterone has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diederich, S; Koetz, KR; Quinkler, M; van Rossum, EF; Ventz, M	1

Other Studies

1 other study(ies) available for 17-alpha-hydroxyprogesterone and Bone Loss, Osteoclastic

Article	Year
BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy. Clinical endocrinology, 2013, Volume: 78, Issue:6 Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adrenal Hyperplasia, Congenital; Adult; Aged; Androstenedione; Bone Density; Bone Resorption; Collagen; Collagen Type I; Cross-Sectional Studies; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Middle Aged; Peptides; Polymorphism, Genetic; Prospective Studies; Receptors, Glucocorticoid	2013

Article

Year

BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.

Clinical endocrinology, 2013, Volume: 78, Issue:6

Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adrenal Hyperplasia, Congenital; Adult; Aged; Androstenedione; Bone Density; Bone Resorption; Collagen; Collagen Type I; Cross-Sectional Studies; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Middle Aged; Peptides; Polymorphism, Genetic; Prospective Studies; Receptors, Glucocorticoid

2013